Symposium VI: Small Cell Lung Cancer (SCLC) "External Control Arm": A Paradigm Shift in Cancer Drug Evaluation/Registration
Keynotes:
“Patient-Centered Datasharing: An Imperative for Agile Innovation”
Paul Howard, PhD, Senior Advisor to the Commissioner, FDA
"NCI Clincial Data Initiatives: Building Coalitions"
Jeff Abrams, MD, National Cancer Institute
Main Sessions:
Best Methods for Developing an External Control Arm
- Brian Alexander, MD, MPH, Harvard/Dana Farber
- Kathryn Lang, MBBS, MRCP, Pfizer
- Yuan-Li Shen, PhD, FDA
- Richard Simon, DSc, NCI
Key Considerations for Small Cell Lung Cancer
- Brian Alexander, Harvard/Dana Farber
- Renzo Canetta, MD, Senior Oncology Advisor
- Jennifer Christian, PharmD, MPH, PhD, FISPE, IQVIA
- Andrea Ferris, MBA, LUNGevity
- Ariel Lopez-Chavez, MD, Roche
Attendee Institutions:
Amgen
Asana BioSciences
AstraZeneca
Bristol-Myers Squibb
Center for Medicare Services
Columbia University Medical Center
Cota Healthcare
Dana-Farber Cancer Institute
Eli Lilly & Co.
EMD Serono
Genentech
Hogan Lovells US LLP
In-Q-Tel
IQVIA
Janssen Research and Development
The Leukemia & Lymphoma Society
Life Sciences Consortium
Loxo Oncology
LUNGevity
Massachusetts General Hospital
MD Anderson Cancer Center
Merck & Co., Inc.
National Cancer Institute, NIH
Novartis
Pfizer
Roche
R Simon Consulting
